agilon health (NYSE:AGL) Trading Down 8% – Here’s Why

agilon health, inc. (NYSE:AGL)’s stock price traded down 8% during trading on Tuesday . The company traded as low as $3.20 and last traded at $3.22. 1,871,620 shares changed hands during mid-day trading, a decline of 62% from the average session volume of 4,954,811 shares. The stock had previously closed at $3.50.

Analyst Upgrades and Downgrades

AGL has been the topic of several research analyst reports. Evercore ISI lowered their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a research report on Wednesday, October 2nd. Deutsche Bank Aktiengesellschaft reduced their price target on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Benchmark reissued a “buy” rating and issued a $9.00 price objective on shares of agilon health in a report on Thursday, August 8th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 target price on shares of agilon health in a report on Wednesday, August 7th. Two equities research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $8.03.

agilon health Price Performance

The firm has a 50 day moving average of $4.07 and a 200-day moving average of $5.29. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.04. The company has a market cap of $1.37 billion, a P/E ratio of -4.70 and a beta of 0.54.

agilon health (NYSE:AGL) last released its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.07). The firm had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.56 billion. agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The company’s revenue for the quarter was up 38.7% compared to the same quarter last year. During the same quarter last year, the business posted ($0.04) earnings per share. On average, equities research analysts predict that agilon health, inc. will post -0.32 EPS for the current year.

Insider Buying and Selling at agilon health

In other news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction dated Thursday, September 12th. The shares were purchased at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares of the company’s stock, valued at $227,102.40. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

Several large investors have recently bought and sold shares of AGL. Wellington Management Group LLP raised its position in shares of agilon health by 2.9% during the 4th quarter. Wellington Management Group LLP now owns 42,510,030 shares of the company’s stock valued at $533,501,000 after buying an additional 1,191,253 shares in the last quarter. Vanguard Group Inc. lifted its stake in shares of agilon health by 0.8% in the 4th quarter. Vanguard Group Inc. now owns 28,576,261 shares of the company’s stock valued at $358,632,000 after purchasing an additional 220,986 shares during the last quarter. Nomura Holdings Inc. purchased a new position in shares of agilon health in the 4th quarter worth approximately $309,000. Renaissance Capital LLC increased its position in shares of agilon health by 3.0% during the 1st quarter. Renaissance Capital LLC now owns 191,122 shares of the company’s stock valued at $1,166,000 after purchasing an additional 5,551 shares during the last quarter. Finally, Counterpoint Mutual Funds LLC purchased a new stake in agilon health during the 1st quarter valued at $421,000.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.